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Abstract
Objective: To assess the adequacy of peritoneal dialysis in Chinese by analyzing the relationship
between weekly urea kinetics (Kt/V) and clinical outcomes.
Methods: A total of 146 patients on continuous ambulatory peritoneal dialysis for more than 6
months in the Shanghai Renji Hospital between July 1997 and March 1999 were enrolled into this
study. They were assigned to three groups according to weekly Kt/V: Group A, Kt/V less than 1.7;
Group B, Kt/V between 1.7 and 2; and Group C, Kt/V greater than 2. Patient and technique survivals
were analyzed by using the log rank method.
Results: The overall 2-year actuarial patient and technique survivals were 90% and 76%,
respectively. The 2-year actuarial patient survival was 78% for Group A, 97% for Group B, and 96%
for Group C (p<0.05). The 2-year technique survival was 56% for Group A, 88% for Group B, and
88% for Group C. Both actuarial patient and technique survivals in Group A were significantly lower
(p<0.05) compared with the other two groups.
Conclusions: The study showed that clinical outcomes in Groups B and C patients were similar.
However, patients with weekly Kt/V values less than 1.7 had poorer clinical outcomes compared
with patients from groups B and C. We conclude that Chinese patients who were receiving peritoneal
ambulatory dialysis may benefit from weekly Kt/V greater than 1.7.
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The relationships among dialysis adequacy, nutrition,
survival, and quality of life are well known (1-4).
Guidelines for peritoneal dialysis adequacy have also
been established (5). An urea kinetics (Kt/V) value of
greater than 2 per week and a weekly creatinine clearance
(CrCl) rate reater than 60 L per week per 1.73 m2 are
generally accepted. However, most of the supporting
results came from studies in white patients (1-4), who
have different demographic characteristics, backgrounds,
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and population mortality rates compared with Chinese
patients (6,7). There are differences such as dietary habits,
body size, and economic constraints between white and
Chinese populations. The dialysis adequacy target of
Chinese patients who are receiving continuous
ambulatory peritoneal dialysis (CAPD) remains
unknown. Preliminary observations in the peritoneal
dialysis unit of the Renji Hospital suggested that Chinese
patients could tolerate a lower dosage of dialysis and still
have excellent outcomes. Recent studies from Hong Kong
also supported a lower target of dialysis adequacy in Chinese
patients (8,9). The aim of this 2-year prospective study was
to investigate the relationship between adequacy and
survival in peritoneal dialysis patients of China.
METHODS
A total of 146 new CAPD patients who received dialysis
in the Renji Hospital between July 1997 and March 1999
were enrolled into in this study. After the first month of
stable peritoneal dialysis, a peritoneal equilibration test
(PET), adequacy (Kt/V, CrCl), and nutritional indexes
were assessed. The PET is a standardized test as described
by Twardowski et al (10) in which, after drainage of the
overnight dwell, 2 L of 2.5% dextrose dialysis solution
is instilled and allowed to dwell for 4 hours. Dialysate
glucose and creatinine are measured initially, and then
after 2 and 4 hours. Serum glucose and creatinine
concentrations are determined at 2 hours. Dialysate-to-
plasma ratios of creatinine (D/P) and the ratio of glucose
at the drain time to the initial dialysate glucose
concentration (D/D0) are determined at 2 and 4 hours.
The peritoneal membrane characteristic was classified
as high, high-average, low-average, and low, according
to published criteria (10).
Dialysis adequacy was quantified by Kt/V and CrCl.
Urine and dialysis effluent was collected during a 24-
hour period, and urea and creatinine concentrations were
determined. Simultaneous plasma urea and creatinine
concentrations were also measured. The results of PET,
dialysis adequacy, residual renal function, and nor-
malized protein catabolic rate (NPCR) were calculated
by PD ADEQUEST 2.0 for Windows software (Baxter
Healthcare, Deerfield, Ill). Nutritional indices included
serum albumin (SAlb), prealbumin, and NPCR. Serum
albumin and prealbumin were measured with an
automatic biochemistry analyzer (Hitachi 7150,
Boehringer Mannheim, Mannheim, Germany). Dialysis
dosage began with 6 L per day.
Patients were assigned to three groups according their
stable Kt/V level: Group A, Kt/V less than 1.7 per week;
Group B, Kt/V between 1.7 and 2; and Group C, Kt/V
greater than 2. The assessment of dialysis adequacy and
nutrition was repeated every 6 months. If the patient had
symptomatic underdialysis, the dosage of peritoneal
dialysis was increased between 8 and 10 L per day. We
modified the dialysis dosage during the study period and
tried to keep Kt/V at the assigned level according to
patient group. The dosages of dialysis were adjusted from
6 to 10 L per day.
Clinical outcomes of this study included actuarial patient
survival, technique survival, peritonitis rate, and duration
of hospitalization. In the analysis of actuarial patient
survival, patient death was counted as an event. In
technique survival, patient death and transferal to long-
term hemodialysis were counted as events.
All data are expressed as mean ± standard deviation.
Comparisons between groups were performed using one-
way analysis of variance. Post hoc analysis was per-
formed using the Bonferroni method. Patient survival
and technique survival analyses were expressed in the
Kaplan-Meier life table and compared by log rank test.
A p value of less than 0.05 was considered significant.
RESULTS
All 146 CAPD patients were followed-up for 24 ± 15
months. There were 77 men and 69 women, and their
mean age was 51.6 ± 14.7 years. During the follow-up
period, 57 patients dropped out. In summary, 15 (10.3%)
patients died, 16 (11%) had kidney transplantation, 19
(13%) were transferred to long-term hemodialysis, and
seven (4.8%) were excluded for other reasons, including
renal functional recovery and transfer to other units.
Of the 15 patients who died, none had clinical underdialysis.
Seven patients died of cardiovascular diseases (three had
polycystic kidney disease). Five patients died of severe
peritonitis. Another three patients had disseminated
carcinoma, and dialysis was discontinued. Most of the
patients who were transferred to hemodialysis were
transferred because of peritonitis.
For the three groups, baseline demographic data, dialysis
adequacy, and nutritional status at the beginning of the
study (month 0) are compared in Tables 1 and 2. During
the study period, Kt/V and NPCR were stable in all three
groups. At month 0, residual renal function, as repre-
sented by the residual glomerular filtration rate, was
better for groups B and C than that of Group A (Table 2).
Residual glomerular filtration rate decreased significantly
for all three groups (Group A, p=0.01; Group B, p=0.0045;
and Group C, p=0.00014).
During the follow-up period, SAlb increased in Group
C (Kt/V >2) but remained static in the other two groups
(Fig. 1). At month 24, there was a significant difference
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in SAlb between groups A and C (28.8 ± 4.9 g/L vs 36.5 ±
5.1 g/L, p<0.05). There were no other differences in
nutritional indices among the three groups. This result
suggests that nutritional status was stable during the 2
years of follow-up. However, patients in Group A should
receive particular attention because the decreasing
tendency of SA1b in this group may suggest a higher
risk of death.
The overall 2-year actuarial patient survival and
technique survival were 90% and 76%, respectively (Fig.
2). The 2-year actuarial patient survival was 78% for
Group A, 97% for Group B, and 96% for Group C (Fig.
3). Two-year technique survival was 56% for Group A,
88% for Group B, and 88% for Group C (Fig. 4).
Actuarial patient survival and technique survival were
both significantly lower in Group A than in the other
two groups (log rank test, p<0.05). The actuarial patient
survival and technique survival were not significantly
different between groups B and C.
Peritonitis rates were one episode in 35 patient-months
for Group A, 34.7 patient-months for Group B, and 40.9
patient-months for Group C. There was one hospital
admission in 40.8 patient-months for Group A, 38.9
patient-months for Group B, and 45.4 patient-months for
Group C. There were no differences in peritonitis and
hospitalization rates among the three groups.
DISCUSSION
Uremia is characterized by retention of a wide spectrum
of toxins that are normally excreted by the kidneys. The
main purpose of renal replacement therapy is to remove
these toxic substances from the body. For peritoneal
dialysis, urea is generally regarded as the surrogate toxin,
and Kt/V is often used as a marker of adequacy.
A number of studies on the relation between peritoneal
dialysis adequacy and patient survival in white patients
were published in the 1990s (1-4). Blake et al (1)
suggested that the risk of death would be increased when
total Kt/V was less than 1.5. Genestier et al (2) found
that patients with Kt/V greater than 1.7 had higher
survival rates than those with levels less than 1.7. Teehan
Table 2. Dialysis adequacy and nutritional status of the three groups at month 0.
Group A Group B Group C
No. of cases 45 34 67
SAlb (g/L) 33.4 ± 5.0 32.4 ± 4.0 33.9 ± 5.4
Serum prealbumin (mmol/L) 394 ± 100 348 ± 86.3 365 ± 85.3
NPCR (g/kg/d) 0.94 ± 0.2 1.00 ± 0.2 1.09 ± 9.3
Kt/V (/week) 1.49 ± 0.17 1.81 ± 0.08 2.38 ± 0.31*
CrCl (L/week/1.73 m2) 50.3 ± 12.0 60.1 ± 14.5 74.9 ± 11.0*
Residual GFR (mL/min) 1.27 ± 1.4 2.21 ± 1.5 3.22 ± 1.8*
Dialysis volume (L/d) 7.25 ± 1.1 7.11 ± 1.1 6.67 ± 1.1†
*p<0.001 by one-way analysis of variance and Bonferroni post hoc analysis.
†p<0.05 by one-way analysis of variance and Bonferroni post hoc analysis.
CrCl = creatinine clearance; GFR = glomerular filtration rate; NPCR = normalized protein catabolic rate; SAlb = serum albumin
Table 1. Background demographic data of the three groups defined by weekly Kt/V.
Group A (Kt/V <1.7) Group B (1.7≤Kt/V≤2) Group C (Kt/V >2)
No. of cases 45 34 67
Sex ratio (M/F) 30:15 20:14 40:27
Age (year) 52.9 ± 14.8 50.9 ± 15.9 50.1 ± 14.3
Body weight (kg) 59.9 ± 9.6 58.4 ± 8.1 53.7 ±  8.3*
Body height (cm) 163.2 ± 8.0 164.5 ± 8.8 161.1 ±  8.3
Body mass index (kg/m2) 22.7 ± 4.1 21.3 ± 2.7 20.6 ± 2.6
Underlying renal diagnosis
     Glomerulonephritis 28 19 46
     Hypertension 6 1 6
     Diabetes 1 3 4
     Polycystic 1 5 1
     Other/unknown 9 6 10
*p<0.001 by one-way analysis of variance and Bonferroni post hoc analysis.
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et al (3) reported that the risk of death would be decreased
when Kt/V was greater than 1.89. In 1996, the Canada-
USA study confirmed that the relative death risk
increased by 5% if Kt/V decreased by 0.1 per week (4).
The study further suggested that the target of Kt/V was
2.1 per week for peritoneal dialysis patients.
Although various target Kt/V values were suggested (1-
4), all authorities agreed that the higher the small solute
clearance, the better the patient survival. In this study,
we also observed similar results in Chinese patients (Figs.
3 and 4). This study, however, is limited by a small
sample number and the fact that all patients came from a
single center, and it was not a strict randomized study.
Furthermore, the study was conducted on the basis of
our previous experience of borderline dosage of dialysis.
During the study period, when we prepared to increase
the dialysis dosage for the patients to achieve the target
level of Kt/V, we first had to tackle the challenge of
financial constraints. As pointed out by Locatelli et al
(11), it was difficult to determine whether “dialysis for
best or dialysis for more” was of higher priority in the
allocation of health care resources, especially in
developing countries.
Results showed that patient survival, technique survival,
and nutritional status were significantly worse in Group
A patients. However, similar clinical outcomes were
observed between patients of groups B and C. This result
suggests that the target Kt/V in this series should be 1.7.
This level is lower than that recommended in Western
studies (3,4). It is important to note that the 2-year
actuarial patient survival was 90% in this study and is
better than that reported from the white population (4).
Two similar studies in Hong Kong Chinese (8,9) also
showed similar results. In one (8), the patient survival
rates were approximately 92%, 56%, and 26% at 1, 5,
and 10 years of follow-up, respectively. The average Kt/V
of that study was 1.76 (8), similar to that reported in this
study. In the other study (9), the 2-year patient survival
rate was 83% when Kt/V was 1.78 (9). Further study is
needed to determine why there were such obvious
discrepancies in patient survival in relation to dialysis
dosage between Chinese and Western patients.
Residual renal function can be better maintained in
peritoneal dialysis patients than in hemodialysis patients.
It has been suggested that residual renal function con-
tributes both to solute clearance (12) and to nutritional
Figure 3. Comparison of patient survival among the three groups.




Figure 1. Changes of serum albumin during follow-up period among
the three groups.
Follow-up duration (months)
Figure 2. Total patient survival and technique survival.
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status (13-15). In a previous study (16), we reported that
patients had better outcomes if their residual renal
function was greater than 2 mL/per minute at the initial
month of dialysis. This might also have contributed to
the favorable outcome in patients of groups B and C in
this study.
This study was based on 2 years of follow-up in a single
center. As a result, there has been concern about the long-
term outcome of the patients. It remains unknown
whether the long-term outcome is different between
groups B and C. A study of extended follow-up period is
required to answer this question. We believe that a similar
outcome between groups B and C could mean a decrease
in the expenditure on peritoneal dialysis and that more
patients with limited social medical resources could be
helped.
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